Hyundai Pharm Cash Flow Conversion Efficiency

Latest as of May 2026: 0.019x

Hyundai Pharm cash flow conversion efficiency. Based on the latest financial reports, Hyundai Pharm (004310) has a cash flow conversion efficiency ratio of 0.019x as of May 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.39 Billion ≈ $1.62 Million USD) by net assets (₩128.05 Billion ≈ $86.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Hyundai Pharm (2010–2025)

Cash flow conversion efficiency of Hyundai Pharm from 2010 to 2025. This chart illustrates how Hyundai Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Hyundai Pharm for real-time trading data and today's change.

Hyundai Pharm Cash Flow Conversion Ratio Explained

Hyundai Pharm cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Hyundai Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hyundai Pharm ranked by their cash flow conversion efficiency. Also see 004310 stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
MCH Group AG SW:MCHN	0.235x
enCore Energy Corp. V:EU	0.050x
Ceres Global Ag Corp TO:CRP	0.066x
THETA GOLD MNS LTD F:3LM	N/A
Wam Strategic Value Ltd AU:WAR	-0.001x
Cloud Technologies S.A WAR:CLD	0.037x
Aurona Industries TWO:8074	0.005x
Auden Techno TW:3138	0.013x

Annual Cash Flow Conversion Efficiency for Hyundai Pharm (2010–2025)

The table below shows the annual cash flow conversion efficiency of Hyundai Pharm from 2010 to 2025. Review 004310 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-11-30	₩82.10 Billion ≈ $55.64 Million	₩-123.29 Million ≈ $-83.55K	-0.002x	+95.00%
2024-11-30	₩79.07 Billion ≈ $53.59 Million	₩-2.37 Billion ≈ $-1.61 Million	-0.030x	+44.10%
2023-11-30	₩84.66 Billion ≈ $57.37 Million	₩-4.55 Billion ≈ $-3.08 Million	-0.054x	-139.98%
2022-11-30	₩86.56 Billion ≈ $58.66 Million	₩11.62 Billion ≈ $7.88 Million	0.134x	+126.60%
2021-11-30	₩86.60 Billion ≈ $58.69 Million	₩5.13 Billion ≈ $3.48 Million	0.059x	-50.56%
2020-11-30	₩90.14 Billion ≈ $61.09 Million	₩10.80 Billion ≈ $7.32 Million	0.120x	+50.79%
2019-11-30	₩87.58 Billion ≈ $59.35 Million	₩6.96 Billion ≈ $4.72 Million	0.079x	+200.09%
2018-11-30	₩107.00 Billion ≈ $72.52 Million	₩2.83 Billion ≈ $1.92 Million	0.026x	+231.16%
2017-11-30	₩98.10 Billion ≈ $66.48 Million	₩-1.98 Billion ≈ $-1.34 Million	-0.020x	+26.42%
2016-11-30	₩100.08 Billion ≈ $67.82 Million	₩-2.75 Billion ≈ $-1.86 Million	-0.027x	-134.94%
2013-11-30	₩101.21 Billion ≈ $68.59 Million	₩7.95 Billion ≈ $5.39 Million	0.079x	+390.34%
2012-11-30	₩99.69 Billion ≈ $67.56 Million	₩-2.70 Billion ≈ $-1.83 Million	-0.027x	-145.03%
2011-11-30	₩104.32 Billion ≈ $70.69 Million	₩6.27 Billion ≈ $4.25 Million	0.060x	+107.53%
2010-11-30	₩92.50 Billion ≈ $62.69 Million	₩2.68 Billion ≈ $1.82 Million	0.029x	--

About Hyundai Pharm

KO:004310 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$137.65 Million

₩203.12 Billion KRW

Market Cap Rank

#17804 Global

#754 in Korea

Share Price

₩6570.00

Change (1 day)

-1.65%

52-Week Range

₩3545.00 - ₩14340.00

All Time High

₩14340.00